Jamunarani Veeraraghavan
Cited by
Cited by
Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers
J Veeraraghavan, Y Tan, XX Cao, JA Kim, X Wang, GC Chamness, ...
Nature communications 5 (1), 1-12, 2014
Radiation-triggered tumor necrosis factor (TNF) α-NFκB cross-signaling favors survival advantage in human neuroblastoma cells
J Veeraraghavan, M Natarajan, S Aravindan, TS Herman, N Aravindan
Journal of Biological Chemistry 286 (24), 21588-21600, 2011
HER2 reactivation through acquisition of the HER2 L755S mutation as a mechanism of acquired resistance to HER2-targeted therapy in HER2+ breast cancer
X Xu, C De Angelis, KA Burke, A Nardone, H Hu, L Qin, J Veeraraghavan, ...
Clinical Cancer Research 23 (17), 5123-5134, 2017
Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells
J Veeraraghavan, M Natarajan, P Lagisetty, V Awasthi, TS Herman, ...
Pancreas 40 (7), 1107-1119, 2011
Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells
N Aravindan, J Veeraraghavan, R Madhusoodhanan, TS Herman, ...
International Journal of Radiation Oncology* Biology* Physics 79 (4), 1206-1215, 2011
Towards personalized treatment for early stage HER2-positive breast cancer
K Goutsouliak, J Veeraraghavan, V Sethunath, C De Angelis, CK Osborne, ...
Nature Reviews Clinical Oncology 17 (4), 233-250, 2020
Low-dose γ-radiation-induced oxidative stress response in mouse brain and gut: Regulation by NFκB–MnSOD cross-signaling
J Veeraraghavan, M Natarajan, TS Herman, N Aravindan
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 718 (1-2 …, 2011
HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade
A Prat, T Pascual, C De Angelis, C Gutierrez, A Llombart-Cussac, T Wang, ...
JNCI: Journal of the National Cancer Institute 112 (1), 46-54, 2020
De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance
J Veeraraghavan, C De Angelis, JS Reis-Filho, T Pascual, A Prat, ...
The Breast 34, S19-S26, 2017
NFκB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation
R Madhusoodhanan, MN Natarajan, J Veeraraghavan, TS Herman, ...
Cancer biology & therapy 8 (9), 765-773, 2009
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
JA Kim, Y Tan, X Wang, X Cao, J Veeraraghavan, Y Liang, DP Edwards, ...
Nature communications 7 (1), 1-17, 2016
Neem leaf extract induces radiosensitization in human neuroblastoma xenograft through modulation of apoptotic pathway
J Veeraraghavan, S Aravindan, M Natarajan, V Awasthi, TS Herman, ...
Anticancer research 31 (1), 161-170, 2011
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
X Fu, R Pereira, C De Angelis, J Veeraraghavan, S Nanda, L Qin, ...
Proceedings of the National Academy of Sciences 116 (52), 26823-26834, 2019
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance
A Nardone, H Weir, O Delpuech, H Brown, C De Angelis, ML Cataldo, ...
British journal of cancer 120 (3), 331-339, 2019
Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications
J Veeraraghavan, J Ma, Y Hu, XS Wang
Breast cancer research and treatment 158 (2), 219-232, 2016
Curcumin-altered p53-response genes regulate radiosensitivity in p53-mutant Ewing's sarcoma cells
J Veeraraghavan, M Natarajan, TS Herman, N Aravindan
Anticancer research 30 (10), 4007-4015, 2010
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
F Schettini, T Pascual, B Conte, N Chic, F Brasó-Maristany, P Galván, ...
Cancer treatment reviews 84, 101965, 2020
NFκB signaling related molecular alterations in human neuroblastoma cells after fractionated irradiation
R Madhusoodhanan, M Natarajan, J Veeraraghavan, TS Herman, ...
Journal of radiation research 50 (4), 311-324, 2009
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer
J Veeraraghavan, C De Angelis, R Mao, T Wang, S Herrera, AC Pavlick, ...
Annals of Oncology 30 (6), 927-933, 2019
Effect of Black Raspberry Extract in Inhibiting NFκ B Dependent Radioprotection in Human Breast Cancer Cells
R Madhusoodhanan, M Natarajan, JVN Singh, A Jamgade, V Awasthi, ...
Nutrition and cancer 62 (1), 93-104, 2009
The system can't perform the operation now. Try again later.
Articles 1–20